Daily non-political popular news in brief.

FDA finds no strong link between tomatoes and reduced cancer risk

A US Food and Drug Administration (FDA) review has found only limited evidence for an association between eating tomatoes and a decreased risk of certain cancers, according to an article published online July 10 in the Journal of the National Cancer Institute.

Read more »

Keywords: fda, strong, link, tomatoes, reduced, cancer, risk, tomatoe

« Previous | Next »

Similar news on "FDA finds no strong link between tomatoes and reduced cancer risk":

1. Fetal cell 'transplant' could be a hidden link between childbirth and reduced risk of breast cancer
   10-02-2007 · EurekAlert!
   Some benefits of motherhood are intangible, but one has been validated through biostatistical research: women who bear children have a reduced risk of developing breast cancer. In Seattle, researchers at the University of Washington and Fred Hutchinson Cancer Research Center believe they have identified a source of this protective effect: fetal cells "transplanted" to the mother before birth.
   Similar news · Read more »
   
2. Gene variations directly link inflammation to an increased risk for lung cancer
   07-03-2007 · EurekAlert!
   Variations in two genes related to inflammation may be a major risk factor for developing lung cancer, according to a team of scientists from the National Cancer Institute and the University of Texas M. D. Anderson Cancer Center. The effect of these genes is especially strong among heavy smokers, suggesting that the inflammatory response is important in modulating the damage caused by tobacco smoke.
   Similar news · Read more »
   
3. No magic tomato? Study breaks link between lycopene and prostate cancer prevention
   05-17-2007 · EurekAlert!
   Tomatoes might be nutritious and tasty, but don't count on them to prevent prostate cancer. In the May issue of Cancer Epidemiology, Biomarkers & Prevention, researchers based at the National Cancer Institute and Fred Hutchinson Cancer Research Center report that lycopene, an antioxidant predominately found in tomatoes, does not effectively prevent prostate cancer. In fact, the researchers noted an association between beta-carotene, an antioxidant related to lycopene, and an increased risk for aggressive prostate cancer.
   Similar news · Read more »
   
4. Other highlights from the March 21 JNCI
   03-20-2007 · EurekAlert!
   Also in the March 21 JNCI are a study on the link between fat intake and breast cancer risk, a plant compound that may decrease breast cancer risk, a critique of the use of progression-free survival in cancer clinical trials, and a mutation to a mismatch repair gene that is associated with colorectal cancer.
   Similar news · Read more »
   
5. Other highlights in the Jan. 8 JNCI
   01-08-2008 · EurekAlert!
   Also in the Jan. 8 JNCI are an association between statin use and reduced cancer risk, a potential colon cancer drug target, a mouse model for studying kidney cancer, and a review of how tumor viruses regulate telomeres.
   Similar news · Read more »
   
6. Study finds that blood test can gauge prostate cancer risk
   01-16-2008 · EurekAlert!
   New genomics research has found that a simple blood test can determine which men are likely to develop prostate cancer. Researchers at Wake Forest University School of Medicine and colleagues found that five genetic variants previously associated with prostate cancer risk have a strong cumulative effect.
   Similar news · Read more »
   
7. Study reveals aspirin's colorectal cancer prevention mechanism
   05-23-2007 · EurekAlert!
   Aspirin therapy's ability to reduce the risk of colorectal cancer, seen in a large number of studies, appears to depend on the drug's inhibition of the COX-2 enzyme, the action that also underlies aspirin's usefulness for treating pain and inflammation. Investigators from Massachusetts General Hospital, Dana-Farber Cancer Institute and Brigham and Women’s Hospital have found that regular aspirin intake only reduced the incidence of colorectal tumors that overexpress COX-2.
   Similar news · Read more »
   
8. Chemotherapy and tamoxifen reduce risk of second breast cancer
   12-25-2007 · EurekAlert!
   Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online Dec. 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5 years, respectively.
   Similar news · Read more »
   
9. Ovarian cancer risk not affected by alcohol and smoking, but reduced by caffeine
   01-22-2008 · EurekAlert!
   A new study has found that cigarette smoking and alcohol consumption do not have an effect on ovarian cancer risk, while caffeine intake may lower the risk, particularly in women not using hormones.
   Similar news · Read more »
   
10. Preventing graft-vs.-host disease after bone marrow transplant -- without toxicity
    12-11-2006 · EurekAlert!
    Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease -- but also suggests that this risk can be reduced by replacing a natural antibiotic that's depleted when patients undergo chemotherapy. A multicenter study led by Children's Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
    Similar news · Read more »